A vitamin supplement has been found to be linked to reduction in skin cancer risks. As per researchers from Australia, they noticed that nicotinamide, a form of vitamin B3, can be associated with a decline of non-melanoma skin cancers by about 23% when it was taken two times a day.

Dr. Diona Damian, a professor of dermatology at the University of Sydney and senior author the new study, said the supplement is safe and inexpensive. According to Damian, good thing about the supplement is that it is widely commercially available. She said the price of Nicotinamide is no more than $10 for a month's supply. The people, who want the supplement, can purchase it from a nearby pharmacy and health food stores.

Damian said, “However, more study is needed before researchers can say whether everyone would benefit from the supplement. It is not something we'd recommend at this stage for the general population”.

According to reports, the new study could be presented at an upcoming annual meeting of the American Society of Clinical Oncology on May 30. The findings of the study have been considered preliminary until they are published in a peer-reviewed journal, the reports stated. The National Health and Medical Research Council of Australia provided funds to the researchers to conduct the study.

According to CDC reports, skin cancer is among the most common forms of cancers in the United States.

Damian said that every year, about 5 million cases are treated at a price of about $4.8 billion.

The American Cancer Society (ACS) stated that common forms of skin cancers grow at slow place and can be treated easily if they are found early. The common skin cancers include basal and squamous cell carcinoma.